An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.

@article{Bonassi2007AnIM,
  title={An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.},
  author={S. Bonassi and A. Znaor and M. Ceppi and C. Lando and W. Chang and N. Holland and M. Kirsch-Volders and E. Zeiger and S. Ban and R. Barale and M. P. Bigatti and C. Bolognesi and A. Cebulska-Wasilewska and E. Fabianova and A. Fucic and L. Hagmar and G. Joksiċ and A. Martelli and Lucia Migliore and E. Mirkova and M. Scarfi and A. Zijno and H. Norppa and M. Fenech},
  journal={Carcinogenesis},
  year={2007},
  volume={28 3},
  pages={
          625-31
        }
}
  • S. Bonassi, A. Znaor, +21 authors M. Fenech
  • Published 2007
  • Medicine, Biology
  • Carcinogenesis
  • The frequency of micronuclei (MN) in peripheral blood lymphocytes (PBL) is extensively used as a biomarker of chromosomal damage and genome stability in human populations. Much theoretical evidence has been accumulated supporting the causal role of MN induction in cancer development, although prospective cohort studies are needed to validate MN as a cancer risk biomarker. A total of 6718 subjects from of 10 countries, screened in 20 laboratories for MN frequency between 1980 and 2002 in ad hoc… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Primary objective: The primary objective of this study is to assess the effect of Ginkgo biloba L. leaf extract (IDN 5933) in comparison to placebo in human subjects treated at… Expand
    ConditionsHealthy
    InterventionDietary Supplement
    Cytokinesis-block micronucleus cytome assay
    • 1,349
    • PDF
    Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer
    • 23
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 50 REFERENCES
    Measurement of micronuclei in lymphocytes.
    • 1,662
    On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls.
    • 55
    • PDF